These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38663175)

  • 21. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
    Zhou N; Zhang R; Liu Y; Wei W
    Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
    Binkley E; Triozzi PL; Rybicki L; Achberger S; Aldrich W; Singh A
    Br J Ophthalmol; 2020 Apr; 104(4):524-528. PubMed ID: 31371315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
    Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
    Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
    Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
    Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uveal melanoma: Long-term survival.
    Radivoyevitch T; Zabor EC; Singh AD
    PLoS One; 2021; 16(5):e0250939. PubMed ID: 34003826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
    Strobel K; Bode B; Dummer R; Veit-Haibach P; Fischer DR; Imhof L; Goldinger S; Steinert HC; von Schulthess GK
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1774-82. PubMed ID: 19495748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation.
    Cohen VM; Carter MJ; Kemeny A; Radatz M; Rennie IG
    Acta Ophthalmol Scand; 2003 Aug; 81(4):383-8. PubMed ID: 12859266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveal melanoma: trends in incidence, treatment, and survival.
    Singh AD; Turell ME; Topham AK
    Ophthalmology; 2011 Sep; 118(9):1881-5. PubMed ID: 21704381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
    Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
    J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
    Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
    Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
    Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of other primary cancer in patients with uveal melanoma: a retrospective cohort study of a Canadian population.
    Callejo SA; Al-Khalifa S; Ozdal PC; Edelstein C; Burnier MN
    Can J Ophthalmol; 2004 Jun; 39(4):397-402. PubMed ID: 15327105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
    Park SJ; Oh CM; Yeon B; Cho H; Park KH
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses.
    Stålhammar G; Coupland SE; Ewens KG; Ganguly A; Heimann H; Shields CL; Damato B
    Ophthalmology; 2024 Apr; 131(4):478-491. PubMed ID: 38071620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
    Ophthalmic Oncology Task Force
    Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.